Product NDC: | 54505-102 |
Proprietary Name: | epinephrine |
Non Proprietary Name: | epinephrine |
Active Ingredient(s): | .3 mg/.3mL & nbsp; epinephrine |
Administration Route(s): | SUBCUTANEOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54505-102 |
Labeler Name: | Lineage Therapeutics Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020800 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20100401 |
Package NDC: | 54505-102-02 |
Package Description: | 2 CASE in 1 CARTON (54505-102-02) > 1 SYRINGE, GLASS in 1 CASE > .3 mL in 1 SYRINGE, GLASS |
NDC Code | 54505-102-02 |
Proprietary Name | epinephrine |
Package Description | 2 CASE in 1 CARTON (54505-102-02) > 1 SYRINGE, GLASS in 1 CASE > .3 mL in 1 SYRINGE, GLASS |
Product NDC | 54505-102 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | epinephrine |
Dosage Form Name | INJECTION |
Route Name | SUBCUTANEOUS |
Start Marketing Date | 20100401 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Lineage Therapeutics Inc. |
Substance Name | EPINEPHRINE |
Strength Number | .3 |
Strength Unit | mg/.3mL |
Pharmaceutical Classes | Adrenergic alpha-Agonists [MoA],Adrenergic beta-Agonists [MoA],alpha-Adrenergic Agonist [EPC],beta-Adrenergic Agonist [EPC],Catecholamine [EPC],Catecholamines [Chemical/Ingredient] |